ondansetron has been researched along with Binge Alcohol Consumption in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornell, J | 1 |
| Conchas, A | 1 |
| Wang, XQ | 1 |
| Fink, JC | 1 |
| Chen, H | 1 |
| Kane, MA | 1 |
| Pilli, N | 1 |
| Ait-Daoud, N | 1 |
| Gorelick, DA | 1 |
| Li, MD | 1 |
| Johnson, BA | 1 |
| Seneviratne, C | 1 |
1 trial available for ondansetron and Binge Alcohol Consumption
| Article | Year |
|---|---|
Validation of serotonin transporter mRNA as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double-blind, crossover trial.
Topics: Adult; Aged; Alcohol Drinking; Binge Drinking; Biomarkers; Cross-Over Studies; Ethanol; Female; Gluc | 2022 |